Biography:
Dr. Hagel currently holds the role of Vice President Innovation with Enveric Biosciences, Inc. (NASDAQ: ENVB). She completed her Ph.D. in 2010 at the University of Calgary, Canada, in the field of specialized plant metabolism and opiate biochemistry. While working as a post-doctoral fellow on a multi-laboratory Genome Canada project aimed at sourcing new genes from medicinal plants, Dr. Hagel co-founded three private and two publicly traded biotechnology companies. Over her career, she has published over 40 peer-reviewed articles, largely in the field of natural products and associated biochemistry.
Title : Isolation of a novel N-methyltransferase from psychedelic cane toad (Rhinella murina) deployable in bio-based production platforms for psychiatric drug discovery